Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice | springermedizin.de
Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice | springermedizin.de
Aliskiren - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Rasilez®
Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy
Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry - Kistner - 2016 - The Journal of Clinical Hypertension - Wiley Online Library
Rasilez® 150 mg 28 St - shop-apotheke.com
Differential effects of aliskiren and hydralazine on protein... | Download Scientific Diagram
PDF] Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. | Semantic Scholar
Aliskiren: the first renin inhibitor for clinical treatment | Nature Reviews Drug Discovery
Rasilez 150 mg 98 St - shop-apotheke.com
Rasilez 300 mg 98 St - shop-apotheke.com
Aliskiren diabetes advice | MIMS online
Effect of direct renin inhibitor aliskiren on circulating endothelial progenitor cells number in patients with type 2 diabetes mellitus and arterial hypertension - Media Centre | EASD
Aliskiren – Wikipedia
Aliskiren: Vorsicht bei Kombination mit Angiotensin-Hemmern